BioSpeedia

📍 Paris, France🗓 Founded 2011👥 3 employees💰 Last funded Jul 2020
Pharmaceutical Manufacturing🌐 biospeedia.com
Website LinkedIn
BioSpeedia was founded by 2 renowned scientists from the Institut Pasteur in 2011: Evelyne Begaud, President and Yves Germani, Chief Scientific Officer. Our clinical research is conducted at St-Priest-en-Jarez, France and clinical testing and quality control in Paris and St. Etienne, France. BioSpeedia is also in the process of relocating part of its overseas production to France. Our global sales and distribution, product registration in various jurisdictions, liasing with regulatory authorities, logistics and shipping is handled by our distribution arm, BioVitess Ltd. which is located in Belfast, UK. All business in the United States, including registration, liaising with regulatory authorities, sales and distribution is handled by our subsidiary BioSpeedia LLC. We also have our subsidiary in Switerland, BioSpeedia International. Forepont provides BioSpeedia access to its global healthcare network, strategic relationships, and access to leading hospitals. Forepont’s Head of Europe, Julien Tizot, is also an Executive Board Member at BioSpeedia.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2011
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
1
Frequently asked questions
Who invested in BioSpeedia?
BioSpeedia has 1 investors on record on gritt.io and 1 late-stage investors.
When did BioSpeedia last raise funding?
The most recent investment in BioSpeedia recorded on gritt.io was in July 2020.
When was BioSpeedia founded?
BioSpeedia was founded in 2011.
What industry is BioSpeedia in?
BioSpeedia operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is BioSpeedia based?
BioSpeedia is headquartered in Paris, France.